You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence and Brief Communications
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Treatment Options for Ductal Carcinoma In Situ of the Breast-Reply

MELVIN J. SILVERSTEIN, MD; JAMES R. WAISMAN, MD; EUGENE D. GIERSON, MD; WILLIAM COLBURN, MD; PARVIS GAMAGAMI, MD; BERNARD S. LEWINSKY, MD
Van Nuys, Calif

Arch Surg. 1991;126(12):1541-1542.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply. —We thank Dr Lawrence for his supportive and thoughtful comments on our article. We would like, however, to take issue with a few points, most importantly, the local failure rate for radiation therapy.

Dr Lawrence states that our local recurrence rate is 7%. He uses this to justify radiation therapy as the treatment of choice for DCIS. He states that we failed "to emphasize the positive aspects" of our study and that we "cast a doubt on the effectiveness" of radiation therapy.

In our published series of 103 patients treated with radiation therapy, seven failed locally, an absolute recurrence rate of 7%. However, during the past few years, we have been accruing patients with DCIS at a rapid rate. This rapid accrual of new patients with DCIS dilutes the study population with freshly diagnosed patients who have not had time to develop recurrence, keeping the absolute recurrence rate . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.